Skip to main content
Top
Published in: Clinical Journal of Gastroenterology 2/2019

01-04-2019 | Case Report

An extremely rare case who underwent total remnant pancreatectomy due to recurrent pancreatic metastasis of intraductal tubulopapillary neoplasm

Authors: Akira Umemura, Kazuyuki Ishida, Hiroyuki Nitta, Takeshi Takahara, Yasushi Hasegawa, Kenji Makabe, Tamotsu Sugai, Akira Sasaki

Published in: Clinical Journal of Gastroenterology | Issue 2/2019

Login to get access

Abstract

We describe a rare case of recurrent pancreatic metastasis of intraductal tubulopapillary neoplasm (ITPN). A 53-year-old woman diagnosed with an intraductal papillary mucinous neoplasm (IPMN) and a pancreatic ductal adenocarcinoma (PDAC) of the pancreatic body underwent a distal pancreatectomy. The tumor was composed of cuboidal, high-grade dysplastic cells proliferating in a tubulopapillary growth pattern without mucin production; hence, the final diagnosis was ITPN. A follow-up computed tomography scan revealed an enhanced 2 cm mass of the pancreatic head 3 years after the surgery. From workup investigations, the patient was diagnosed with PDAC or a recurrent ITPN of the remnant pancreas. A total remnant pancreatectomy was then performed. Histopathological findings revealed that the new ITPN had the same features as the prior ITPN. In IPMNs, the presence of an invasive component and high-grade dysplasia can lead to progression to a recurring IPMN and the development of PDAC. Because there have been few reports of recurrent ITPN developing into PDAC, the risk factors for ITPN have not been investigated. Because of the uncertain clinicopathological characteristics of ITPN, more data should be gathered to assess the long-term outcome and malignant potential of ITPN.
Literature
1.
go back to reference Adsay NV, Fukushima N, Furukawa T, et al Intraductal neoplasms of the pancreas. In: Bosman FT, Carneiro F, Hruban RH, Theise ND, editors. World Health Organization classification of tumours of the digestive system. 4th ed. Lyon: IARC; 2010. pp. 304–13. Adsay NV, Fukushima N, Furukawa T, et al Intraductal neoplasms of the pancreas. In: Bosman FT, Carneiro F, Hruban RH, Theise ND, editors. World Health Organization classification of tumours of the digestive system. 4th ed. Lyon: IARC; 2010. pp. 304–13.
2.
go back to reference Yogi T, Hijioka S, Imaoka H, et al. Risk factors for postoperative recurrence of intraductal papillary mucinous neoplasms of the pancreas based on a long-term follow-up study: proposals for follow-up strategies. J Hepatobiliary Pancreat Sci. 2015;22:757–65.CrossRefPubMed Yogi T, Hijioka S, Imaoka H, et al. Risk factors for postoperative recurrence of intraductal papillary mucinous neoplasms of the pancreas based on a long-term follow-up study: proposals for follow-up strategies. J Hepatobiliary Pancreat Sci. 2015;22:757–65.CrossRefPubMed
3.
go back to reference Yamaguchi H, Shimizu M, Ban S, et al. Intraductal tubulopapillary neoplasms of the pancreas distinct from pancreatic intraepithelial neoplasia and intraductal papillary mucinous neoplasms. Am J Surg Pathol. 2009;33:1164–72.CrossRefPubMed Yamaguchi H, Shimizu M, Ban S, et al. Intraductal tubulopapillary neoplasms of the pancreas distinct from pancreatic intraepithelial neoplasia and intraductal papillary mucinous neoplasms. Am J Surg Pathol. 2009;33:1164–72.CrossRefPubMed
4.
go back to reference Tajiri T, Tate G, Matsumoto K, et al. Diagnostic challenge: intraductal neoplasms of the pancreatobiliary system. Pathol Res Pract. 2012;208:691–6.CrossRefPubMed Tajiri T, Tate G, Matsumoto K, et al. Diagnostic challenge: intraductal neoplasms of the pancreatobiliary system. Pathol Res Pract. 2012;208:691–6.CrossRefPubMed
5.
go back to reference Kitaguchi K, Kato Y, Kojima M, et al. A resected case of intraductal tubulopapillary neoplasm of the pancreas: report of a case. Int Surg. 2015;100:281–6.CrossRefPubMedPubMedCentral Kitaguchi K, Kato Y, Kojima M, et al. A resected case of intraductal tubulopapillary neoplasm of the pancreas: report of a case. Int Surg. 2015;100:281–6.CrossRefPubMedPubMedCentral
6.
go back to reference Date K, Okabayashi T, Shima Y, et al. Clinicopathological features and surgical outcomes of intraductal tubulopapillary neoplasm of the pancreas: a systematic review. Langenbecks Arch Surg. 2016;401:1391–6.CrossRef Date K, Okabayashi T, Shima Y, et al. Clinicopathological features and surgical outcomes of intraductal tubulopapillary neoplasm of the pancreas: a systematic review. Langenbecks Arch Surg. 2016;401:1391–6.CrossRef
7.
go back to reference Yamaguchi H, Kuboki Y, Hatori T, et al. Somatic mutations in PIK3CA and activation of AKT in intraductal tubulopapillary neoplasms of the pancreas. Am J Pathol. 2011;351:1812–7.CrossRef Yamaguchi H, Kuboki Y, Hatori T, et al. Somatic mutations in PIK3CA and activation of AKT in intraductal tubulopapillary neoplasms of the pancreas. Am J Pathol. 2011;351:1812–7.CrossRef
8.
go back to reference Urata T, Naito Y, Nagamine M, et al. Intraductal tubulopapillary neoplasm of the pancreas with somatic BRAF mutation. Clin J Gastroenterol. 2012;5:413–20.CrossRefPubMed Urata T, Naito Y, Nagamine M, et al. Intraductal tubulopapillary neoplasm of the pancreas with somatic BRAF mutation. Clin J Gastroenterol. 2012;5:413–20.CrossRefPubMed
9.
go back to reference Basturk O, Adsay V, Askan G, et al. Intraductal tubulopapillary neoplasm of the pancreas: a clinicopathologic and immunohistochemical analysis of 33 cases. Am J Surg Pathol. 2017;41:313–25.CrossRefPubMedPubMedCentral Basturk O, Adsay V, Askan G, et al. Intraductal tubulopapillary neoplasm of the pancreas: a clinicopathologic and immunohistochemical analysis of 33 cases. Am J Surg Pathol. 2017;41:313–25.CrossRefPubMedPubMedCentral
10.
go back to reference Kuscher S, Steinle H, Soleiman A, et al. Intraductal tubulopapillary neoplasm (ITPN) of the pancreas associated with an invasive component: a case report with review of the literature. World J Surg Oncol. 2017;15:203.CrossRefPubMedPubMedCentral Kuscher S, Steinle H, Soleiman A, et al. Intraductal tubulopapillary neoplasm (ITPN) of the pancreas associated with an invasive component: a case report with review of the literature. World J Surg Oncol. 2017;15:203.CrossRefPubMedPubMedCentral
11.
go back to reference Kölby D, Thilén J, Andersson R, et al. Multifocal intraductal tubulopapillary neoplasm of the pancreas with total pancreatectomy: report of a case and review of literature. Int J Clin Exp Pathol. 2015;8:9672–80.PubMedPubMedCentral Kölby D, Thilén J, Andersson R, et al. Multifocal intraductal tubulopapillary neoplasm of the pancreas with total pancreatectomy: report of a case and review of literature. Int J Clin Exp Pathol. 2015;8:9672–80.PubMedPubMedCentral
12.
go back to reference Pea A, Yu J, Rezaee N, et al. Targeted DNA sequencing reveals patterns of local progression in the pancreatic remnant following resection of intraductal papillary mucinous neoplasm (IPMN) of the pancreas. Ann Surg. 2017;266:133–41.CrossRefPubMedPubMedCentral Pea A, Yu J, Rezaee N, et al. Targeted DNA sequencing reveals patterns of local progression in the pancreatic remnant following resection of intraductal papillary mucinous neoplasm (IPMN) of the pancreas. Ann Surg. 2017;266:133–41.CrossRefPubMedPubMedCentral
13.
go back to reference Fujita Y, Kitago M, Masugi Y, et al. Two cases of pancreatic ductal adenocarcinoma with intrapancreatic metastasis. World J Gastroenterol. 2016;22:9222–8.CrossRefPubMedPubMedCentral Fujita Y, Kitago M, Masugi Y, et al. Two cases of pancreatic ductal adenocarcinoma with intrapancreatic metastasis. World J Gastroenterol. 2016;22:9222–8.CrossRefPubMedPubMedCentral
Metadata
Title
An extremely rare case who underwent total remnant pancreatectomy due to recurrent pancreatic metastasis of intraductal tubulopapillary neoplasm
Authors
Akira Umemura
Kazuyuki Ishida
Hiroyuki Nitta
Takeshi Takahara
Yasushi Hasegawa
Kenji Makabe
Tamotsu Sugai
Akira Sasaki
Publication date
01-04-2019
Publisher
Springer Japan
Published in
Clinical Journal of Gastroenterology / Issue 2/2019
Print ISSN: 1865-7257
Electronic ISSN: 1865-7265
DOI
https://doi.org/10.1007/s12328-018-0913-x

Other articles of this Issue 2/2019

Clinical Journal of Gastroenterology 2/2019 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine